Search for: "Doe v. Mylan Pharmaceuticals, Inc." Results 101 - 120 of 163
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Mar 2011, 12:53 pm by Christa Culver
Rodriguez Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
3 May 2016, 1:42 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 Aug 2011, 3:31 am by Marie Louise
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs)   Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin – US: CAFC… [read post]
10 Oct 2014, 1:16 pm by Rebecca Tushnet
  Defendants argued that under Mylan Labs., Inc. v. [read post]
18 May 2016, 8:19 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
27 May 2011, 8:56 am by Kali Borkoski
  Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to… [read post]
17 Apr 2012, 5:55 pm by FDABlog HPM
” The Court says that its decision is consistent with the circumstances surrounding the aftermath of the Federal Circuit’s decision in Mylan Pharmaceuticals, Inc. v. [read post]
9 Aug 2012, 5:00 am by Bexis
(trochar) Deposition2000-01-16 Doe v. [read post]
28 Jun 2016, 6:41 am by Dennis Crouch
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
2 Mar 2012, 6:52 am by Bexis
(trochar) Deposition2000-01-16 Doe v. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]